PPT-Long Acting Injectable Agents for HIV Prevention
Author : giovanna-bartolotta | Published Date : 2017-12-17
Nyaradzo M Mgodi MBChB MMed On behalf of the HPTN076 Team UZUCSF Annual Research Day May 05 2017 Harare Background Introduction to Rilpivirine TMC 278 HPTN076
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Long Acting Injectable Agents for HIV Pr..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Long Acting Injectable Agents for HIV Prevention: Transcript
Nyaradzo M Mgodi MBChB MMed On behalf of the HPTN076 Team UZUCSF Annual Research Day May 05 2017 Harare Background Introduction to Rilpivirine TMC 278 HPTN076 Study Design. David Hubacher, PhD. Senior Epidemiologist. FHI. Outline of Talk. Description of long-acting reversible contraception (LARC). Worldwide use of long-acting. Advantages and Disadvantages. Service delivery factors. Coordinators Follow-Up and Final Visits Procedures Review. Dial 1-919-962-2731. 1. GO TO MEETING. We will pause between agenda items to take questions.. To ask a question enter it in the chat box on the right side of your screen. Anand. . Bhagwat. Mining Bolt & . Cable . Bolting Systems Lead. Orica Ground Support. Georgetown, Kentucky . Dale King. Customer Technical Relations Manager. Bekaert. . Corporation. Van Buren, . Rebecca McDonald. National Addiction . Centre. King’s College London. Declarations. RM has undertaken an unpaid student industry placement with . Mundipharma. Research Ltd., with focus on the analysis of naloxone nasal spray formulations. PrEP. Anton Pozniak . MD FRCP. Consultant Physician . . Disclosures. I have received honoraria, travel sponsorship and research grants from:. Gilead Sciences . Janssen. MSD. ViiV Healthcare. BUT… success depends on adherence.. Cabotegravir. in Low-Risk . HIV-uninfected . Women and . Men. R. . Landovitz. , . S. . Li, . B. . Grinsztejn. , . H. . Dawood, . A. . Liu, . M. Magnus, . M. . Hosseinipour. , . R. . Panchia. , . L. . for PrEP. Sinead Delany-Moretlwe. University of the Witwatersrand. IAS, Amsterdam, July 2018. Women account for more than half of adults living with HIV globally. Young women are twice as likely to be living with HIV as young men. Sinead Delany-Moretlwe. Wits RHI, University of the Witwatersrand, Johannesburg. Conflict of Interest. I have received drug donation awarded to my institution from Gilead Sciences.. New option for prevention. delivering the ng technologies rapeutics by the potentials e. Dr Joël Richard is currently Head of Technical & Pharmaceutical Operations at MedinCell (Montpellier, France). He is leading all the ph bronchodilators include Combiventum Take with Respimatium Take with nebulizer These medications are long-acting Long-acting bronchodilators are used regularly to open the airways and keep them open Lo Shelly Malhotra,. Senior Director, Global Access, IAVI. No conflicts of interest are declared. Co-authors. S. Malhotra, M. Keane, A. Kurzman, N. Sender, M. Price, IAVI, New York, United States. Evolving Access Pathways for Long-Acting HIV Prevention Products. Diabetes Mellitus . Summary of Drugs Used in the Treatment of Diabetes. Diabetes Treatment . A person with . type 1 diabetes . must rely on . exogenous insulin . to . control hyperglycemia. , . avoid . Presented by Carol Nati MD, MS, DFAPA. Medical Director, MHMR of Tarrant County. Overview. Long Acting Injectable Antipsychotic Medications are underutilized in Texas.. They have been proven to work well.. Last Updated: October 6, 2023. Prepared by:. David H. Spach, MD. Brian R. Wood, MD. Oral Cabotegravir (Optional) . Cabotegravir Injectable (IM). Cabotegravir for HIV PrEP. INSTI. 30 mg. Oral Cabotegravir .
Download Document
Here is the link to download the presentation.
"Long Acting Injectable Agents for HIV Prevention"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents